Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mizon is a prominent South Korean cosmeceutical company, operating under the parent firm PFD Co., Ltd., that specializes in advanced skincare formulations. The company is widely recognized for its pioneering use of snail mucin filtrate and peptide-based technologies to address dermatological concerns such as aging, scarring, and hydration. Mizon maintains its own dedicated R&D facility, the Creative Beauty Lab, where it integrates biotechnology with traditional skincare ingredients to develop high-efficacy products. Its business model focuses on the global commercialization of K-beauty innovations, with a strong presence in both Asian and Western markets. The company's portfolio includes specialized lines for collagen regeneration, barrier repair, and intensive blemish care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mizon.